View in EDS HTML Full Text PDF Full Text

Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.

Saved in:
Bibliographic Details
Title: Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.
Authors: Parra-Izquierdo, Iván1,2 (AUTHOR) parraizq@ohsu.edu, Melrose, Alexander R.1 (AUTHOR), Pang, Jiaqing2 (AUTHOR), Lakshmanan, Hari Hara Sudhan2 (AUTHOR), Reitsma, Stéphanie E.2 (AUTHOR), Vavilapalli, Sai Hitesh1 (AUTHOR), Larson, Mark K.3 (AUTHOR), Shatzel, Joseph J.2,4 (AUTHOR), McCarty, Owen J. T.2,4 (AUTHOR), Aslan, Joseph E.1,2,5 (AUTHOR)
Source: Platelets. 2022, Vol. 33 Issue 3, p404-415. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09537104
DOI:10.1080/09537104.2021.1934665